| Selenides and Diselenides: A Review of Their Anticancer and Chemopreventive Activity M Álvarez-Pérez, W Ali, MA Marć, J Handzlik, E Domínguez-Álvarez Molecules 23 (3), 628, 2018 | 138 | 2018 |
| Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line M Gajdács, G Spengler, C Sanmartín, MA Marć, J Handzlik, ... Bioorganic & Medicinal Chemistry Letters 27 (4), 797-802, 2017 | 77 | 2017 |
| Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance G Spengler, M Gajdács, MA Marć, E Domínguez-Álvarez, C Sanmartín Molecules 24 (2), 336, 2019 | 71 | 2019 |
| Identification of selenocompounds with promising properties to reverse cancer multidrug resistance E Domínguez-Álvarez, M Gajdács, G Spengler, JA Palop, MA Marć, ... Bioorganic & medicinal chemistry letters 26 (12), 2821-2824, 2016 | 62 | 2016 |
| The 1, 3, 5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment G Latacz, A Lubelska, M Jastrzębska-Więsek, A Partyka, MA Marć, ... International Journal of Molecular Sciences 20 (14), 3420, 2019 | 43 | 2019 |
| Antiviral, Antimicrobial and Antibiofilm Activity of Selenoesters and Selenoanhydrides G Spengler, A Kincses, T Mosolygó, MA Marć, M Nové, M Gajdács, ... Molecules 24 (23), 4264, 2019 | 41 | 2019 |
| Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents E Domínguez-Álvarez, B Rácz, MA Marć, MJ Nasim, N Szemerédi, ... Drug Resistance Updates 63, 100844, 2022 | 38 | 2022 |
| The anticancer and chemopreventive activity of selenocyanate-containing compounds W Ali, M Álvarez-Pérez, MA Marć, N Salardón-Jiménez, J Handzlik, ... Current Pharmacology Reports 4, 468-481, 2018 | 35 | 2018 |
| Selenocompounds as Novel Antibacterial Agents and Bacterial Efflux Pump Inhibitors T Mosolygó, A Kincses, A Csonka, ÁS Tönki, K Witek, C Sanmartín, ... Molecules 24 (8), 1487, 2019 | 34 | 2019 |
| Selenazolinium Salts as “Small Molecule Catalysts” with High Potency against ESKAPE Bacterial Pathogens K Witek, MJ Nasim, M Bischoff, R Gaupp, P Arsenyan, J Vasiljeva, ... Molecules 22 (12), 2174, 2017 | 33 | 2017 |
| Pronounced activity of aromatic selenocyanates against multidrug resistant ESKAPE bacteria MJ Nasim, K Witek, A Kincses, AY Abdin, E Żesławska, MA Marć, ... New Journal of Chemistry 43 (15), 6021-6031, 2019 | 27 | 2019 |
| Are the Hydantoin-1, 3, 5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile … A Lubelska, G Latacz, M Jastrzębska-Więsek, M Kotańska, R Kurczab, ... Molecules 24 (24), 4472, 2019 | 22 | 2019 |
| Nucleic acid vaccination strategies against infectious diseases MA Marć, E Domínguez-Álvarez, C Gamazo Expert Opinion on Drug Delivery 12 (12), 1851-1865, 2015 | 22 | 2015 |
| Novel latonduine derived proligands and their copper (II) complexes show cytotoxicity in the nanomolar range in human colon adenocarcinoma cells and in vitro cancer selectivity F Bacher, C Wittmann, M Nové, G Spengler, MA Marć, EA Enyedy, ... Dalton Transactions 48 (28), 10464-10478, 2019 | 20 | 2019 |
| Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition AVB Besleaga I, Stepanenko I, Petrasheuskaya T.V., Darvasiova D, Breza M ... Inorganic Chemistry 60, 11297–11319, 2021 | 16 | 2021 |
| Antimicrobial, Anticancer and Multidrug-Resistant Reversing Activity of Novel Oxygen-, Sulfur-and Selenoflavones and Bioisosteric Analogues MA Marć, A Kincses, B Rácz, MJ Nasim, M Sarfraz, C Lázaro-Milla, ... Pharmaceuticals 13 (12), 453, 2020 | 16 | 2020 |
| Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders MA Marć, R Jastrząb, J Mytych Nutrients 14 (19), 3967, 2022 | 14 | 2022 |
| In vitro biotransformation, safety, and chemopreventive action of novel 8-methoxy-purine-2, 6-dione derivatives MA Marć, E Domínguez-Álvarez, K Słoczyńska, P Żmudzki, ... Applied biochemistry and biotechnology 184, 124-139, 2018 | 13 | 2018 |
| Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity MA Marć, E Domínguez-Álvarez, G Latacz, A Doroz-Płonka, C Sanmartín, ... Pharmaceutics 14 (2), 367, 2022 | 11 | 2022 |
| DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System V Vella, M Giuliano, ML Nicolosi, MG Majorana, MA Marć, MG Muoio, ... Biomolecules 11 (7), 926, 2021 | 11 | 2021 |
Enrique Domínguez ÁlvarezInstituto de Química Orgánica General, Consejo Superior de Investigaciones Científicas (IQOG-CSIC)Verified email at iqog.csic.es
